Xeltis raises €20.5m to advance aXess trial and European rollout

Horizon 3 Healthcare led the round, adding to €50m secured in 2025 as the medtech company prepares for FDA submission, US market entry and expanded manufacturing.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.